• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is AMA M2 a useful serologic test for screening high-risk patients for PBC?: Editorial on "Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive".

作者信息

Heo Nae-Yun

机构信息

Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Korea.

出版信息

Clin Mol Hepatol. 2025 Apr;31(2):640-641. doi: 10.3350/cmh.2025.0117. Epub 2025 Feb 13.

DOI:10.3350/cmh.2025.0117
PMID:39947709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12016620/
Abstract
摘要

相似文献

1
Is AMA M2 a useful serologic test for screening high-risk patients for PBC?: Editorial on "Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive".AMA M2是一种用于筛查原发性胆汁性胆管炎（PBC）高危患者的有用血清学检测方法吗？：关于“抗线粒体M2抗体阳性的健康体检人群中原发性胆汁性胆管炎的预测”的社论
Clin Mol Hepatol. 2025 Apr;31(2):640-641. doi: 10.3350/cmh.2025.0117. Epub 2025 Feb 13.
2
Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive.抗线粒体M2抗体阳性的健康体检人群中原发性胆汁性胆管炎的预测
Clin Mol Hepatol. 2025 Apr;31(2):474-488. doi: 10.3350/cmh.2024.0416. Epub 2024 Dec 30.
3
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients.偶然抗线粒体M2抗体阳性患者发生原发性胆汁性胆管炎的风险。
Hepatol Forum. 2023 May 18;4(2):69-73. doi: 10.14744/hf.2023.2023.0016. eCollection 2023 Mar.
4
[An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].[药物性肝损伤和原发性胆汁性胆管炎患者抗线粒体M2亚型血清学特征分析]
Zhonghua Gan Zang Bing Za Zhi. 2019 Apr 20;27(4):298-303. doi: 10.3760/cma.j.issn.1007-3418.2019.04.011.
5
Distinction between Mitochondrial Antibody-Positive and -Negative Primary Biliary Cholangitis.线粒体抗体阳性与阴性原发性胆汁性胆管炎的鉴别
Case Rep Gastroenterol. 2023 Jan 6;17(1):14-20. doi: 10.1159/000528437. eCollection 2023 Jan-Dec.
6
Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?通过免疫印迹法检测自身免疫性胆管炎中抗-M2抗体的IgA、IgM和IgG亚类：自身免疫性胆管炎是原发性胆汁性肝硬化的早期阶段吗？
J Gastroenterol. 1999 Oct;34(5):607-12. doi: 10.1007/s005350050380.
7
Anti-mitochondrial antibodies detection assays for diagnosis of primary biliary cholangitis in southern Tunisia population.突尼斯南部人群中用于原发性胆汁性胆管炎诊断的抗线粒体抗体检测试验
Ann Biol Clin (Paris). 2022 Sep 1;80(5):423-429. doi: 10.1684/abc.2022.1761.
8
Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis.检测抗线粒体 2-氧代酸脱氢酶复合体亚基抗体用于原发性胆汁性胆管炎的诊断。
Clin Immunol. 2024 Nov;268:108749. doi: 10.1016/j.clim.2021.108749. Epub 2021 May 1.
9
[The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].抗线粒体抗体及其亚型在原发性胆汁性肝硬化诊断中的价值
Zhonghua Gan Zang Bing Za Zhi. 2005 Jan;13(1):9-11.
10
A population-based characterization study of 
anti-mitochondrial M2 antibodies and its consistency with anti-mitochondrial antibodies.一项基于人群的抗线粒体 M2 抗体特征研究及其与抗线粒体抗体的一致性。
Lab Med. 2023 Nov 2;54(6):618-625. doi: 10.1093/labmed/lmad018.

引用本文的文献

1
Correspondence to editorial on "Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive".致关于“抗线粒体M2抗体阳性健康体检人群中原发性胆汁性胆管炎的预测”的社论的信函
Clin Mol Hepatol. 2025 Apr;31(2):e194-e196. doi: 10.3350/cmh.2025.0181. Epub 2025 Feb 24.

本文引用的文献

1
Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive.抗线粒体M2抗体阳性的健康体检人群中原发性胆汁性胆管炎的预测
Clin Mol Hepatol. 2025 Apr;31(2):474-488. doi: 10.3350/cmh.2024.0416. Epub 2024 Dec 30.
2
Diagnostic value of anti-mitochondrial antibody in patients with primary biliary cholangitis: A systemic review and meta-analysis.抗线粒体抗体在原发性胆汁性胆管炎患者中的诊断价值：系统评价和荟萃分析。
Medicine (Baltimore). 2023 Nov 10;102(45):e36039. doi: 10.1097/MD.0000000000036039.
3
A population-based characterization study of 
anti-mitochondrial M2 antibodies and its consistency with anti-mitochondrial antibodies.一项基于人群的抗线粒体 M2 抗体特征研究及其与抗线粒体抗体的一致性。
Lab Med. 2023 Nov 2;54(6):618-625. doi: 10.1093/labmed/lmad018.
4
The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC.在无基线原发性胆汁性胆管炎（PBC）但存在偶然抗线粒体抗体的患者中，原发性胆汁性胆管炎（PBC）的未来风险较低。
Hepatol Commun. 2022 Nov;6(11):3112-3119. doi: 10.1002/hep4.2067. Epub 2022 Aug 23.
5
Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.六年随访中抗线粒体抗体阳性患者新发原发性胆汁性胆管炎的发生率较低。
J Intern Med. 2020 Apr;287(4):395-404. doi: 10.1111/joim.13005. Epub 2019 Dec 4.
6
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.EASL 临床实践指南：原发性胆汁性胆管炎患者的诊断和管理。
J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18.
7
Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis.大规模对具有抗线粒体抗体但尚未确诊为原发性胆汁性胆管炎的患者进行特征描述研究。
Hepatology. 2017 Jan;65(1):152-163. doi: 10.1002/hep.28859. Epub 2016 Nov 10.
8
The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis.抗线粒体抗体及M2亚型检测对原发性胆汁性肝硬化诊断的准确性：一项荟萃分析
Clin Chem Lab Med. 2014 Nov;52(11):1533-42. doi: 10.1515/cclm-2013-0926.